目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End Use
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Organoids & Spheroids Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. High adoption of organoids & spheroids in drug discovery
3.2.1.2. Technological advancements
3.2.1.3. Rising demand for tissue engineering & organ transplantation
3.2.2. Market restraint analysis
3.2.2.1. Challenges associated with 3D cell culturing
3.2.2.2. Ethical issues associated with organoid & spheroid cultures
3.3. Organoids & Spheroids Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis
4.1. Segment Dashboard
4.2. Global Organoids & Spheroids Market: Type Movement Analysis
4.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Organoids
4.4.1. Organoids market estimates and forecast, 2018 - 2030
4.4.2. Organoids by Type
4.4.2.1. Neural Organoids
4.4.2.1.1. Neural organoids market estimates and forecast, 2018 - 2030
4.4.2.2. Hepatic Organoids
4.4.2.2.1. Hepatic organoids market estimates and forecast, 2018 - 2030
4.4.2.3. Intestinal organoids
4.4.2.3.1. Intestinal organoids market estimates and forecast, 2018 - 2030
4.4.2.4. Other organoids
4.4.2.4.1. Other organoids market estimates and forecast, 2018 - 2030
4.4.3. Organoids by Method
4.4.3.1. General Submerged Method for Organoid Culture
4.4.3.1.1. General Submerged Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.2. Crypt Organoid Culture Techniques
4.4.3.2.1. Crypt Organoid Culture Techniques market estimates and forecast, 2018 - 2030
4.4.3.3. Air Liquid Interface (ALI) Method for Organoid Culture
4.4.3.3.1. ALI Method for Organoid Culture market estimates and forecast, 2018 - 2030
4.4.3.4. Clonal Organoids from Lgr5+ Cells
4.4.3.4.1. Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
4.4.3.5. Brain and Retina Organoid Formation Protocol
4.4.3.5.1. Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
4.4.3.6. Others
4.4.3.6.1. Others market estimates and forecast, 2018 - 2030
4.4.4. Organoids by Source
4.4.4.1. Primary Tissues
4.4.4.1.1. Primary tissues market estimates and forecast, 2018 - 2030
4.4.4.2. Stem Cells
4.4.4.2.1. Stem cells market estimates and forecast, 2018 - 2030
4.5. Spheroids
4.5.1. Spheroids market estimates and forecast, 2018 - 2030
4.5.2. Spheroids by Type
4.5.2.1. Multicellular tumor spheroids (MCTS)
4.5.2.1.1. MCTS market estimates and forecast, 2018 - 2030
4.5.2.2. Neurospheres
4.5.2.2.1. Neurospheres market estimates and forecast, 2018 - 2030
4.5.2.3. Mammospheres
4.5.2.3.1. Mammospheres market estimates and forecast, 2018 - 2030
4.5.2.4. Hepatospheres
4.5.2.4.1. Hepatospheres market estimates and forecast, 2018 - 2030
4.5.2.5. Embryoid bodies
4.5.2.5.1. Embryoid bodies market estimates and forecast, 2018 - 2030
4.5.3. Spheroids by Method
4.5.3.1. Micropatterned Plates
4.5.3.1.1. Micropatterned Plates market estimates and forecast, 2018 - 2030
4.5.3.2. Low Cell Attachment Plates
4.5.3.2.1. Low Cell Attachment Plates market estimates and forecast, 2018 - 2030
4.5.3.3. Hanging Drop Method
4.5.3.3.1. Hanging Drop Method for spheroid Culture market estimates and forecast, 2018 - 2030
4.5.3.4. Others
4.5.3.4.1. Other methods for spheroid culture market estimates and forecast, 2018 - 2030
4.5.4. Spheroids by Source
4.5.4.1. Cell Line
4.5.4.1.1. Cell line market estimates and forecast, 2018 - 2030
4.5.4.2. Primary Cell
4.5.4.2.1. Primary cell market estimates and forecast, 2018 - 2030
4.5.4.3. iPSCs Derived Cells
4.5.4.3.1. iPSCs Derived Cells market estimates and forecast, 2018 - 2030

Chapter 5. End Use Business Analysis
5.1. Segment Dashboard
5.2. Global Organoids & Spheroids Market: End Use Movement Analysis
5.3. Global Organoids & Spheroids Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Biotechnology and Pharmaceutical Industries
5.4.1. Biotechnology and Pharmaceutical Industries market estimates and forecast 2018 to 2030 (USD million)
5.5. Academic & Research Institutes
5.5.1. Academic & Research Institutes market estimates and forecast 2018 to 2030 (USD Million)
5.6. Hospitals and Diagnostic Centers
5.6.1. Hospitals and Diagnostic Centers market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Application Business Analysis
6.1. Segment Dashboard
6.2. Global Organoids & Spheroids Market: Application Movement Analysis
6.3. Global Organoids & Spheroids Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Developmental Biology
6.4.1. Developmental Biology market estimates and forecast 2018 to 2030 (USD million)
6.5. Personalized Medicine
6.5.1. Personalized Medicine market estimates and forecast 2018 to 2030 (USD Million)
6.6. Regenerative Medicine
6.6.1. Regenerative Medicine market estimates and forecast 2018 to 2030 (USD million)
6.7. Disease Pathology Studies
6.7.1. Disease Pathology Studies market estimates and forecast 2018 to 2030 (USD Million)
6.8. Drug Toxicity & Efficacy Testing
6.8.1. Drug Toxicity & Efficacy Testing market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Regional Business Analysis, By Country, Type, Application, & End Use
7.1. Segment Dashboard
7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4. Europe
7.4.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. UK market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. France market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Denmark market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Sweden market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Target Disease Prevalence
7.4.9.3. Competitive Scenario
7.4.9.4. Norway market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5. Asia Pacific
7.5.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.2. China
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. China market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.3. Japan
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (Volume, Thousand)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. India market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.5. Australia
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.6. Thailand
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Competitive Scenario
7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.5.7. South Korea
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Competitive Scenario
7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6. Latin America
7.6.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7. MEA
7.7.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.2. Saudi Arabia
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Competitive Scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.3. South Africa
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Competitive Scenario
7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Target Disease Prevalence
7.7.4.3. Competitive Scenario
7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Target Disease Prevalence
7.7.5.3. Competitive Scenario
7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Merck KGaA
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Lonza
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. 3D Biomatrix
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. 3D Biotek LLC
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. AMS Biotechnology (Europe) Limited
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Cellesce Ltd
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Corning Incorporated
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Greiner Bio-One
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hubrecht Organoid Technology (HUB)
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. InSphero
8.4.11.1. Company overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Prellis Biologics
8.4.12.1. Company overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. STEMCELL Technologies Inc.
8.4.13.1. Company overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives

List of Tables
Table 1 List of Abbreviation
Table 2 North America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 3 North America organoids and spheroids market, by End Use, 2018 - 2030 (USD Million)
Table 4 North America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 5 North America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 8 U.S. organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 9 Canada organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 10 Canada organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 11 Canada organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 12 Mexico organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 14 Mexico organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 15 Europe organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 16 Europe organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 17 Europe organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 18 Europe organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 19 Germany organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 20 Germany organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 21 Germany organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 22 UK organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 23 UK organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 24 UK organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 25 France organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 26 France organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 27 France organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 28 Italy organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 29 Italy organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 30 Italy organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 31 Spain organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 32 Spain organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 33 Spain organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 35 Sweden organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 36 Sweden organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 37 Norway organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 38 Norway organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 39 Norway organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 41 Denmark organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 42 Denmark organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 43 APAC organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 44 APAC organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 45 APAC organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 46 APAC organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 47 China organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 48 China organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 49 China organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 50 Japan organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 51 Japan organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 52 Japan organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 53 India organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 54 India organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 55 India organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 56 Thailand organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 58 Thailand organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 59 South Korea organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 61 South Korea organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 62 Australia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 63 Australia organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 64 Australia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 66 Latin America organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 67 Latin America organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 68 Latin America organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 69 Brazil organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 70 Brazil organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 71 Brazil organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 74 Argentina organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa organoids and spheroids market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 81 South Africa organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 85 UAE organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 86 UAE organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 87 UAE organoids and spheroids market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait organoids and spheroids market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait organoids and spheroids market, by end use, 2018 - 2030 (USD Million)
Table 90 Kuwait organoids and spheroids market, by application, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Organoids and Spheroids: Market Outlook
Fig. 9 Organoids and Spheroids competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Organoids and Spheroids market driver impact
Fig. 13 Organoids and Spheroids market restraint impact
Fig. 14 Organoids and Spheroids market strategic initiatives analysis
Fig. 15 Organoids and Spheroids market: type movement analysis
Fig. 16 Organoids and Spheroids market: type outlook and key takeaways
Fig. 17 Neural organoids market estimates and forecast, 2018 - 2030
Fig. 18 Hepatic organoids market estimates and forecast, 2018 - 2030
Fig. 19 Intestinal organoids market estimates and forecast, 2018 - 2030
Fig. 20 Other organoids market estimates and forecast, 2018 - 2030
Fig. 21 General submerged method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 22 Crypt organoid culture techniques market estimates and forecast, 2018 - 2030
Fig. 23 ALI method for organoid culture market estimates and forecast, 2018 - 2030
Fig. 24 Clonal Organoids from Lgr5+ Cells market estimates and forecast, 2018 - 2030
Fig. 25 Brain and Retina Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 26 Others Organoid Formation Protocol market estimates and forecast, 2018 - 2030
Fig. 27 Primary tissues market estimates and forecast, 2018 - 2030
Fig. 28 Stem cells market estimates and forecast, 2018 - 2030
Fig. 29 Spheroids market estimates and forecast, 2018 - 2030
Fig. 30 MCTS market estimates and forecast, 2018 - 2030
Fig. 31 Neurospheres market estimates and forecast, 2018 - 2030
Fig. 32 Mammospheres market estimates and forecast, 2018 - 2030
Fig. 33 Hepatospheres market estimates and forecast, 2018 - 2030
Fig. 34 Embryoid bodies market estimates and forecast, 2018 - 2030
Fig. 35 Micropatterned plates market estimates and forecast, 2018 - 2030
Fig. 36 Low cell attachment plates market estimates and forecast, 2018 - 2030
Fig. 37 Hanging drop method for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 38 Other methods for spheroid culture market estimates and forecast, 2018 - 2030
Fig. 39 Cell line market estimates and forecast, 2018 - 2030
Fig. 40 Primary cell market estimates and forecast, 2018 - 2030
Fig. 41 iPSCs derived cells market estimates and forecast, 2018 - 2030
Fig. 42 Organoids and spheroids market: End Use movement analysis
Fig. 43 Organoids and spheroids market: End Use outlook and key takeaways
Fig. 44 Biotechnology and pharmaceutical industries market estimates and forecast, 2018 - 2030
Fig. 45 Academic & research institutes market estimates and forecast, 2018 - 2030
Fig. 46 Hospitals and diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 47 Organoids and spheroids market: application movement analysis
Fig. 48 Organoids and spheroids market: application outlook and key takeaways
Fig. 49 Developmental biology market estimates and forecast, 2018 - 2030
Fig. 50 Personalized medicine market estimates and forecast, 2018 - 2030
Fig. 51 Regenerative medicine market estimates and forecast, 2018 - 2030
Fig. 52 Disease pathology studies market estimates and forecast, 2018 - 2030
Fig. 53 Drug toxicity & efficacy testing market estimates and forecast, 2018 - 2030
Fig. 54 Global Organoids and spheroids market: regional movement analysis
Fig. 55 Global Organoids and spheroids market: regional outlook and key takeaways
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2018 - 2030
Fig. 58 US key country dynamics
Fig. 59 US market estimates and forecast, 2018 - 2030
Fig. 60 Canada key country dynamics
Fig. 61 Canada market estimates and forecast, 2018 - 2030
Fig. 62 Mexico key country dynamics
Fig. 63 Mexico market estimates and forecast, 2018 - 2030
Fig. 64 Europe
Fig. 65 Europe market estimates and forecast, 2018 - 2030
Fig. 66 UK key country dynamics
Fig. 67 UK market estimates and forecast, 2018 - 2030
Fig. 68 Germany key country dynamics
Fig. 69 Germany market estimates and forecast, 2018 - 2030
Fig. 70 France key country dynamics
Fig. 71 France market estimates and forecast, 2018 - 2030
Fig. 72 Italy key country dynamics
Fig. 73 Italy market estimates and forecast, 2018 - 2030
Fig. 74 Spain key country dynamics
Fig. 75 Spain market estimates and forecast, 2018 - 2030
Fig. 76 Sweden key country dynamics
Fig. 77 Sweden market estimates and forecast, 2018 - 2030
Fig. 78 Norway key country dynamics
Fig. 79 Norway market estimates and forecast, 2018 - 2030
Fig. 80 Denmark key country dynamics
Fig. 81 Denmark market estimates and forecast, 2018 - 2030
Fig. 82 Asia Pacific
Fig. 83 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 84 China key country dynamics
Fig. 85 China market estimates and forecast, 2018 - 2030
Fig. 86 Japan key country dynamics
Fig. 87 Japan market estimates and forecast, 2018 - 2030
Fig. 88 India key country dynamics
Fig. 89 India market estimates and forecast, 2018 - 2030
Fig. 90 Australia key country dynamics
Fig. 91 Australia market estimates and forecast, 2018 - 2030
Fig. 92 Thailand key country dynamics
Fig. 93 Thailand market estimates and forecast, 2018 - 2030
Fig. 94 South Korea key country dynamics
Fig. 95 South Korea market estimates and forecast, 2018 - 2030
Fig. 96 Latin America
Fig. 97 Latin America market estimates and forecast, 2018 - 2030
Fig. 98 Brazil key country dynamics
Fig. 99 Brazil market estimates and forecast, 2018 - 2030
Fig. 100 Argentina key country dynamics
Fig. 101 Argentina market estimates and forecast, 2018 - 2030
Fig. 102 Middle East and Africa
Fig. 103 Middle East and Africa market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia key country dynamics
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 South Africa key country dynamics
Fig. 107 South Africa market estimates and forecast, 2018 - 2030
Fig. 108 UAE key country dynamics
Fig. 109 UAE market estimates and forecast, 2018 - 2030
Fig. 110 Kuwait key country dynamics
Fig. 111 Kuwait market estimates and forecast, 2018 - 2030